Anheuser-Busch InBev, makers of global beer brand, Budweiser, has agreed to a $100 million partnership with medical cannabis company Tilray to research marijuana-infused drinks for the Canadian market.
AB InBev and Tilray in announced on Wednesday that each company will commit a $50 million investment to the project.
Both companies will study non-alcoholic beverages containing cannabidiol, or CBD and THC in a bid to manufacture cannabis-infused beer.
CBD has been said to have calming and healing effects, and THC, a compound in the plant is known for its psychoactive effects.
In October, Canada legalized recreational marijuana leading to increased interest from beer and tobacco companies to capitalise on opportunities within the market.
